Join our Community
Support ToI and remove all ads
Learn more
×

Jonathan Stempel

Workers operates next to a sign of Swiss banking giant UBS on the top of a building in Zurich, on March 4, 2026. (Fabrice COFFRINI / AFP)
April 7, 2026, 10:38 pm
US judge rejects bid by Swiss Bank UBS to limit its liability for Nazi-linked crimes
Banking giant had sought to expand $1.25 billion settlement from 1999 to encompass newly discovered ties between Nazi officials and UBS-owned Credit Suisse
By Jonathan Stempel
This photograph shows a sign of Swiss giant banking UBS at a branch in Zurich on March 4, 2026. (Fabrice COFFRINI / AFP)
March 11, 2026, 8:34 am
UBS asks US judge to shield it from further investigation into Nazi bank accounts
Former Credit Suisse reached $1.25b settlement in 1999 over WWII-era crimes, is now resistant to handing over 150 documents it says are protected by attorney-client privilege
By Jonathan Stempel
Anti-Israel and pro-Palestinian students and others gather outside of Cooper Union in Manhattan to protest the school's stance on Israel on May 9, 2024 in New York City. (Spencer Platt/Getty Images/AFP)
January 8, 2026, 8:18 pm
New York’s Cooper Union settles campus antisemitism case, pledges reforms
College reaches settlement with 10 Jewish students who were locked in a library amid unruly anti-Israel protest weeks after October 7 attack
By Jonathan Stempel
Binance CEO Changpeng Zhao leaves the US District Court on November 21, 2023, in Seattle, Washington (David Ryder / GETTY IMAGES NORTH AMERICA / Getty Images via AFP)
November 25, 2025, 2:11 am
Hundreds of Oct. 7 victims sue world’s biggest crypto exchange for Hamas money-laundering
US suit alleges Binance and its founder knowingly enabled multiple terror groups to move over $1B through its platform, including after massacre, and after paying earlier $4B fine
By Jonathan Stempel
A Monarch butterfly lands on a flower outside the Ben & Jerry's Ice Cream shop, in Burlington, Vermont, July 20, 2021. (AP Photo/Charles Krupa)
January 25, 2025, 9:24 am
Ben & Jerry’s accuses parent company Unilever of muzzling it because of Trump
Ice Cream company says food giant threatening to shut down its independent board, amends complaint it had filed claiming it is being silenced over efforts to support Palestinians
By Jessica DiNapoli and Jonathan Stempel
OpenAI CEO Sam Altman attends an Apple event announcing new products in Cupertino, California, June 10, 2024. (AP Photo/Jeff Chiu)
January 8, 2025, 7:17 pm
OpenAI head Sam Altman accused by sister of raping her, family says claim untrue
Accuser has mental health issues and refuses treatment, say other family members, as she seeks at least $75,000 in damages for alleged abuse when ChatGPT creator was a teen
By Sarah Young and Jonathan Stempel
The Jerusalem compound of computer chip manufacturer Intel, May 18, 2016. (Yonatan Sindel/Flash90)
August 14, 2024, 2:20 pm
Israeli fired from Intel sues company in New York over supervisor’s antisemitism
Plaintiff requests permission to sue anonymously as he accuses his former boss of celebrating antisemitism, Hamas, terrorism on social media
By Jonathan Stempel
New York University students and anti-Israel, pro-Palestinian supporters rally outside the NYU Stern School of Business building, April 22, 2024, in New York. (AP Photo/Mary Altaffer)
July 9, 2024, 3:23 am
NYU settles federal antisemitism lawsuit brought by Jewish students
School was accused of unevenly enforcing anti-discrimination policies by allowing chants such as ‘Gas the Jews’ and ‘Hitler was right’; terms of deal not immediately released
By Jonathan Stempel
Tom Cruise poses for the media during the 'Top Gun Maverick' UK premiere at a central London cinema, on May 19, 2022. (AP Photo/Alberto Pezzali)
April 9, 2024, 4:46 pm
LA court rules ‘Top Gun: Maverick’ didn’t infringe Israeli writer’s copyright
Lawyer for Ehud Yonay’s widow and son will appeal district judge’s decision in case accusing Paramount Pictures of pilfering from 1983 piece on US Navy fighter pilot school
By Jonathan Stempel
Pro-Palestinian, anti-Israel supporters gather for a rally at Harvard University in Cambridge, Massachusetts, on October 14, 2023. (Joseph Prezioso/AFP)
January 12, 2024, 6:41 am
Harvard sued by Jewish students over ‘rampant’ antisemitism on campus
Seeking injunction to stop alleged Civil Rights Act violations, plaintiffs assert school selectively enforcing anti-discrimination policies to avoid protecting Jews from harassment
By Jonathan Stempel
Copaxone, the only non-interferon multiple sclerosis treatment, was developed by Teva Pharmaceuticals in the mid-1990s. (Weizmann Institute of Science/JTA)
From the WebAugust 19, 2020, 2:05 am
US sues Teva over $300 million in false claims for multiple sclerosis drug
Drugmaker accused of causing submission of false claims to Medicare by using kickbacks to boost sales of its drug Copaxone
By Jonathan Stempel and Nate Raymond
Load More
Sign in or Join The Times of Israel Community
Paying ToI Community members are invited to comment on articles
Please use the following structure: example@domain.com
Or Continue with
By joining you agree to the terms and conditions
Register to continue
Or Continue with
Log in to continue
Sign in or Join The Times of Israel Community
Only ToI Community members can comment below articles
Forgot your password? / Send me a login link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.
Back to top
Never miss breaking news on Israel
Get notifications to stay updated
You're subscribed
image
Register for free
and continue reading
Registering allows you to manage your newsletters and alerts and helps us improve your experience. It takes just a few seconds.
Already registered? Enter your email to sign in.
Please use the following structure: example@domain.com
Or Continue with
By registering you agree to the terms and conditions. Once registered, you’ll receive our Daily Edition email for free.
Register to continue
Or Continue with
Log in to continue
Sign in or Register
I forgot my password / Send me a sign in link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.